Your browser doesn't support javascript.
loading
Targeting natural splicing plasticity of APOBEC3B restricts its expression and mutagenic activity.
Rouf Banday, A; Onabajo, Olusegun O; Lin, Seraph Han-Yin; Obajemu, Adeola; Vargas, Joselin M; Delviks-Frankenberry, Krista A; Lamy, Philippe; Bayanjargal, Ariunaa; Zettelmeyer, Clara; Florez-Vargas, Oscar; Pathak, Vinay K; Dyrskjøt, Lars; Prokunina-Olsson, Ludmila.
Affiliation
  • Rouf Banday A; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Onabajo OO; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Lin SH; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Obajemu A; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Vargas JM; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Delviks-Frankenberry KA; Viral Mutation Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.
  • Lamy P; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
  • Bayanjargal A; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Zettelmeyer C; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Florez-Vargas O; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Pathak VK; Viral Mutation Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.
  • Dyrskjøt L; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
  • Prokunina-Olsson L; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. prokuninal@mail.nih.gov.
Commun Biol ; 4(1): 386, 2021 03 22.
Article in En | MEDLINE | ID: mdl-33753867
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Proteins / Biomarkers, Tumor / Minor Histocompatibility Antigens / Mutagenesis / Alternative Splicing / Cytidine Deaminase Type of study: Prognostic_studies Limits: Humans Language: En Journal: Commun Biol Year: 2021 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Proteins / Biomarkers, Tumor / Minor Histocompatibility Antigens / Mutagenesis / Alternative Splicing / Cytidine Deaminase Type of study: Prognostic_studies Limits: Humans Language: En Journal: Commun Biol Year: 2021 Type: Article Affiliation country: United States